Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000572959 | SCV000662567 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-04-17 | criteria provided, single submitter | clinical testing | The c.698dupC pathogenic mutation (also known as p.K234*), located in coding exon 4 of the MSH6 gene, results from a duplication of C at nucleotide position 698. This changes the amino acid from a lysine to a stop codon within coding exon 4. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Myriad Genetics, |
RCV003451219 | SCV004187320 | pathogenic | Lynch syndrome 5 | 2023-08-10 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |
Baylor Genetics | RCV003459293 | SCV004196348 | likely pathogenic | Endometrial carcinoma | 2021-11-04 | criteria provided, single submitter | clinical testing |